| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | Oct 2, 2025 | Monopar Therapeutics | CEO | Sell | 45.0 | -2,646 | -0.75% | ✗ | $216.1K |
| Sep 24, 2025 | Sep 26, 2025 | Monopar Therapeutics | CEO | Sell | 15.0 | -550,229 | -66.92% | ✗ | $35M |
| Jul 14, 2025 | Jul 16, 2025 | Monopar Therapeutics | CEO | Sell | 20.0 | -16,800 | -1.84% | ✗ | $672K |
| Jun 30, 2025 | Jul 2, 2025 | Monopar Therapeutics | CEO | Sell | 45.0 | -5,865 | -0.65% | ✗ | $209.8K |
| Apr 2, 2025 | Apr 4, 2025 | Monopar Therapeutics | CEO | Sell | 17.5 | -33,334 | -3.90% | ✗ | $1.2M |
| Mar 31, 2025 | Apr 2, 2025 | Monopar Therapeutics | CEO | Sell | 51.3 | -1,204 | -0.13% | ✗ | $43.8K |
| Mar 4, 2025 | Mar 7, 2025 | Monopar Therapeutics | CEO | Sell | 47.5 | -1,759 | -0.19% | ✗ | $55.8K |
| Dec 31, 2024 | Jan 2, 2025 | Monopar Therapeutics | CEO | Sell | 51.3 | -2,209 | -0.24% | ✗ | $48.6K |
| Sep 30, 2024 | Oct 2, 2024 | Monopar Therapeutics | CEO | Sell | 51.3 | -1,918 | -0.21% | ✗ | $12.9K |
| Jun 30, 2024 | Jul 2, 2024 | Monopar Therapeutics | CEO | Sell | 52.5 | -8,684 | -0.19% | ✗ | $6.3K |
| Mar 31, 2024 | Apr 2, 2024 | Monopar Therapeutics | CEO | Sell | 52.5 | -7,172 | -0.16% | ✗ | $4.9K |
| Dec 31, 2023 | Jan 3, 2024 | Monopar Therapeutics | CEO | Sell | 52.5 | -10,796 | -0.12% | ✗ | $3.7K |
| Sep 30, 2023 | Oct 3, 2023 | Monopar Therapeutics | CEO | Sell | 52.5 | -7,172 | -0.16% | ✗ | $4.4K |
| Jun 30, 2023 | Jul 3, 2023 | Monopar Therapeutics | CEO | Sell | 52.5 | -10,269 | -0.23% | ✗ | $8.8K |
| Mar 31, 2023 | Apr 4, 2023 | Monopar Therapeutics | CEO | Sell | 52.5 | -4,286 | -0.10% | ✗ | $6K |
| Dec 31, 2022 | Jan 3, 2023 | Monopar Therapeutics | CEO | Sell | 51.3 | -7,141 | -0.08% | ✗ | $16.9K |
| Sep 30, 2022 | Oct 3, 2022 | Monopar Therapeutics | CEO | Sell | 52.5 | -4,077 | -0.09% | ✗ | $6.2K |
| Jun 30, 2022 | Jul 1, 2022 | Monopar Therapeutics | CEO | Sell | 51.3 | -6,999 | -0.16% | ✗ | $16.1K |
| Mar 31, 2022 | Apr 1, 2022 | Monopar Therapeutics | CEO | Sell | 52.5 | -1,155 | -0.03% | ✗ | $2.9K |
| Jan 1, 2022 | Jan 4, 2022 | Monopar Therapeutics | CEO | Sell | 52.5 | -2,327 | -0.05% | ✗ | $7.5K |
| Dec 31, 2021 | Jan 4, 2022 | Monopar Therapeutics | CEO | Sell | 52.5 | -1,364 | -0.03% | ✗ | $4.4K |
| Sep 30, 2021 | Oct 1, 2021 | Monopar Therapeutics | CEO | Sell | 52.5 | -1,155 | -0.03% | ✗ | $5.6K |
| Jun 30, 2021 | Jul 2, 2021 | Monopar Therapeutics | CEO | Sell | 51.3 | -2,310 | -0.05% | ✗ | $13.6K |
| Feb 11, 2021 | Feb 16, 2021 | Monopar Therapeutics | CEO | Sell | 36.3 | -125,000 | -2.84% | ✓ | $1.8M |
| Jan 1, 2021 | Jan 5, 2021 | Monopar Therapeutics | CEO | Sell | 51.3 | -2,327 | -0.05% | ✗ | $14.2K |
| Dec 18, 2019 | Dec 20, 2019 | Monopar Therapeutics | CEO | Buy | 92.5 | +125,000 | 2.92% | ✗ | $1M |